Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants

Dadaev, T Saunders, EJ Newcombe, PJ Anokian, E Leongamornlert, DA Brook, MN Cieza-Borrella, C Mijuskovic, M Wakerell, S Olama, AAA Schumacher, FR Berndt, SI Benlloch, S Ahmed, M Goh, C Sheng, X Zhang, Z Muir, K Govindasami, K Lophatananon, A Stevens, VL Gapstur, SM Carter, BD Tangen, CM Goodman, P Thompson, IM Batra, J Chambers, S Moya, L Clements, J Horvath, L Tilley, W Risbridger, G Gronberg, H Aly, M Nordström, T Pharoah, P Pashayan, N Schleutker, J Tammela, TLJ Sipeky, C Auvinen, A Albanes, D Weinstein, S Wolk, A Hakansson, N West, C Dunning, AM Burnet, N Mucci, L Giovannucci, E Andriole, G Cussenot, O Cancel-Tassin, G Koutros, S Freeman, LEB Sorensen, KD Orntoft, TF Borre, M Maehle, L Grindedal, EM Neal, DE Donovan, JL Hamdy, FC Martin, RM Travis, RC Key, TJ Hamilton, RJ Fleshner, NE Finelli, A Ingles, SA Stern, MC Rosenstein, B Kerns, S Ostrer, H Lu, YJ Zhang, HW Feng, N Mao, X Guo, X Wang, G Sun, Z Giles, GG Southey, MC MacInnis, RJ Fitzgerald, LM Kibel, AS Drake, BF Vega, A Gómez-Caamaño, A Fachal, L Szulkin, R Eklund, M Kogevinas, M Llorca, J Castaño-Vinyals, G Penney, KL Stampfer, M Park, JY Sellers, TA

Abstract: